Ivona Aksentijevich Selected Research

human ADA2 protein

1/2019

Human adenosine deaminase 2 deficiency: A multi-faceted inborn error of immunity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ivona Aksentijevich Research Topics

Disease

35	Inflammation (Inflammations) 01/2022 - 12/2002
12	Cryopyrin-Associated Periodic Syndromes 01/2021 - 12/2002
11	Fever (Fevers) 04/2021 - 12/2002
9	Familial Mediterranean Fever (Periodic Disease) 01/2022 - 12/2002
8	Pyogenic arthritis, pyoderma gangrenosum, and acne 01/2022 - 01/2003
6	autosomal dominant familial Periodic fever 03/2012 - 09/2002
4	Necrosis 01/2021 - 12/2002
4	Mevalonate Kinase Deficiency 01/2021 - 09/2003
4	Infections 01/2019 - 06/2009
3	deficiency of adenosine deaminase 2 01/2022 - 01/2019
3	Vasculitis (Vasculitides) 01/2022 - 01/2019
3	Stroke (Strokes) 01/2022 - 01/2019
3	Skin Diseases (Skin Disease) 01/2021 - 11/2013
3	Systemic Vasculitis 01/2019 - 04/2016
3	Exanthema (Rash) 01/2012 - 09/2003
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2022 - 01/2017
2	Lymphadenitis (Adenitis) 01/2022 - 04/2011
2	Enterocolitis 01/2022 - 10/2012
2	VEXAS syndrome 10/2021 - 12/2020
2	Thrombocytopenia (Thrombopenia) 10/2021 - 02/2013
2	Lipodystrophy 01/2021 - 11/2015
2	Arthritis (Polyarthritis) 06/2019 - 12/2018
2	Schmid-Fraccaro syndrome 01/2018 - 03/2014
2	Urticaria (Hives) 09/2015 - 10/2012
2	Periostitis 11/2013 - 12/2011
2	Osteomyelitis 11/2013 - 12/2011
2	Arthralgia (Joint Pain) 10/2012 - 09/2003
2	Common Variable Immunodeficiency 01/2012 - 09/2010
2	Crohn Disease (Crohn's Disease) 01/2003 - 12/2002
2	Blau syndrome 01/2003 - 12/2002
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Hypercholesterolemia 01/2022
1	Simian Acquired Immunodeficiency Syndrome 01/2022
1	Macrophage Activation Syndrome 01/2022
1	Rheumatic Diseases (Rheumatism) 01/2022
1	Multiple Myeloma 10/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 10/2021
1	Lymphopenia (Lymphocytopenia) 10/2021
1	Macrocytic Anemia 10/2021
1	Chronic Granulomatous Disease 04/2021
1	Headache (Headaches) 04/2021
1	Bites and Stings (Sting) 01/2021
1	COVID-19 01/2021
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2021
1	Lymphadenopathy 01/2020
1	Psoriatic Arthritis 06/2019
1	Rheumatoid Arthritis 06/2019
1	Joint Diseases (Joint Disease) 06/2019
1	Genetic Risk Score 01/2019
1	Cytopenia 01/2019
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2019

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2002
11	PyrinIBA 01/2022 - 12/2002
10	CytokinesIBA 01/2022 - 12/2002
7	Adenosine DeaminaseIBA 01/2022 - 03/2014
7	InflammasomesIBA 01/2022 - 01/2015
7	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2017 - 08/2006
5	EnzymesIBA 01/2022 - 09/2003
5	InterleukinsIBA 12/2018 - 01/2013
5	AutoantibodiesIBA 10/2012 - 12/2002
4	Tumor Necrosis Factor InhibitorsIBA 01/2022 - 01/2018
4	Biological ProductsIBA 06/2019 - 03/2008
4	Etanercept (Enbrel)FDA Link 01/2019 - 09/2003
4	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 12/2002
4	Interleukin-1 (Interleukin 1)IBA 01/2015 - 12/2002
4	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 11/2013 - 12/2002
3	Phosphotransferases (Kinase)IBA 01/2020 - 01/2012
3	NF-kappa B (NF-kB)IBA 01/2018 - 12/2002
2	Janus Kinase InhibitorsIBA 01/2022 - 04/2021
2	tofacitinibIBA 01/2022 - 04/2021
2	Interleukin-18 (Interleukin 18)IBA 01/2022 - 01/2013
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2021 - 11/2013
2	veltuzumabIBA 01/2021 - 01/2018
2	CholesterolIBA 01/2020 - 09/2003
2	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 01/2017
2	Interleukin-17 (Interleukin 17)IBA 12/2018 - 02/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2012 - 09/2002
2	AntigensIBA 07/2011 - 01/2009
2	human PSTPIP1 proteinIBA 11/2010 - 03/2008
2	NucleotidesIBA 09/2010 - 12/2002
1	Indicators and Reagents (Reagents)IBA 01/2022
1	InterferonsIBA 01/2022
1	Ferritins (Ferritin)IBA 04/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2021
1	AntibodiesIBA 04/2021
1	SteroidsIBA 04/2021
1	Pattern Recognition ReceptorsIBA 01/2021
1	Death Domain ReceptorsIBA 01/2021
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021
1	Protein Isoforms (Isoforms)IBA 12/2020
1	CaspasesIBA 01/2020
1	tocilizumab (atlizumab)FDA Link 06/2019
1	Adalimumab (Humira)FDA Link 06/2019
1	Abatacept (Orencia)FDA Link 06/2019
1	Prednisone (Sone)FDA LinkGeneric 06/2019
1	human ADA2 proteinIBA 01/2019

Therapy/Procedure

11	Therapeutics 01/2019 - 09/2002
1	Cell Transplantation 01/2021
1	Biological Therapy 06/2019
1	Hematopoietic Stem Cell Transplantation 01/2019